Antipodes Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,007
| Closed | -$90.5K | – | 116 |
|
|
2025
Q1 | $90.5K | Buy |
+1,007
| New | +$90.5K | ﹤0.01% | 75 |
|
|
2022
Q1 | – | Sell |
-1,095,099
| Closed | -$113M | – | 39 |
|
|
2021
Q4 | $113M | Buy |
1,095,099
+84,271
| +8% | +$8.72M | 4.07% | 10 |
|
|
2021
Q3 | $127M | Sell |
1,010,828
-36,160
| -3% | -$4.53M | 4.33% | 8 |
|
|
2021
Q2 | $130M | Sell |
1,046,988
-191,530
| -15% | -$23.8M | 4.69% | 9 |
|
|
2021
Q1 | $146M | Sell |
1,238,518
-5,320
| -0.4% | -$628K | 5.93% | 4 |
|
|
2020
Q4 | $146M | Buy |
1,243,838
+322,345
| +35% | +$37.8M | 6.33% | 4 |
|
|
2020
Q3 | $95.8M | Buy |
921,493
+161,688
| +21% | +$16.8M | 4.39% | 8 |
|
|
2020
Q2 | $69.7M | Buy |
759,805
+19,918
| +3% | +$1.83M | 3.15% | 11 |
|
|
2020
Q1 | $66.7M | Buy |
739,887
+134,412
| +22% | +$12.1M | 3.49% | 15 |
|
|
2019
Q4 | $68.7M | Sell |
605,475
-18,893
| -3% | -$2.14M | 3.09% | 12 |
|
|
2019
Q3 | $67.8M | Buy |
624,368
+414,448
| +197% | +$45M | 3.24% | 15 |
|
|
2019
Q2 | $20.4M | Buy |
+209,920
| New | +$20.4M | 0.94% | 22 |
|